Literature DB >> 25671806

The untapped potential of office-based buprenorphine treatment.

Stacey C Sigmon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25671806     DOI： 10.1001/jamapsychiatry.2014.2421

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  28 in total

1.  Factors associated with treatment retention in pregnant women with opioid use disorders prescribed methadone or electing non-pharmacological treatment.

Authors:  Brandi Jancaitis; Sydney Kelpin; Saba Masho; James May; Nancy A Haug; Dace Svikis
Journal:  Women Health       Date:  2019-05-08

2.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

3.  Supporting Providers After Drug Overdose Death.

Authors:  Amy M Yule; Frances R Levin
Journal:  Am J Psychiatry       Date:  2019-03-01       Impact factor: 18.112

4.  The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.

Authors:  Sharon Reif; Mary F Brolin; Maureen T Stewart; Thomas J Fuchs; Elizabeth Speaker; Shayna B Mazel
Journal:  J Subst Abuse Treat       Date:  2019-07-19

5.  Financing Buprenorphine Treatment in Primary Care: A Microsimulation Model.

Authors:  Jonathan E Fried; Sanjay Basu; Russell S Phillips; Bruce E Landon
Journal:  Ann Fam Med       Date:  2020-11       Impact factor: 5.166

6.  Telemedicine's Role in Addressing the Opioid Epidemic.

Authors:  Y Tony Yang; Eric Weintraub; Rebecca L Haffajee
Journal:  Mayo Clin Proc       Date:  2018-08-07       Impact factor: 7.616

7.  Barriers to Buprenorphine Expansion in Ohio: A Time-Elapsed Qualitative Study.

Authors:  Todd Molfenter; Maureen Fitzgerald; Nora Jacobson; Dennis McCarty; Andrew Quanbeck; Mark Zehner
Journal:  J Psychoactive Drugs       Date:  2019-02-07

8.  Cost-effectiveness of emergency department-initiated treatment for opioid dependence.

Authors:  Susan H Busch; David A Fiellin; Marek C Chawarski; Patricia H Owens; Michael V Pantalon; Kathryn Hawk; Steven L Bernstein; Patrick G O'Connor; Gail D'Onofrio
Journal:  Addiction       Date:  2017-08-16       Impact factor: 6.526

9.  Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors:  Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal:  Addict Behav       Date:  2015-07-29       Impact factor: 3.913

Review 10.  Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update.

Authors:  Kathleen T Brady; Jenna L McCauley; Sudie E Back
Journal:  Am J Psychiatry       Date:  2015-09-04       Impact factor: 18.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.